These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 161153)

  • 1. Thymic inducers of human T-lymphocyte differentiation in vitro and in vivo.
    Touraine JL; Touraine F
    Ann N Y Acad Sci; 1979; 332():64-9. PubMed ID: 161153
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to thymopoietin pentapeptide in patient with DiGeorge syndrome.
    Aiuti F; Businco L; Rossi P; Quinti I
    Lancet; 1980 Jan; 1(8159):91. PubMed ID: 6101433
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro differentiation of human marrow T cell precursors by thymic factors in severe combined immunodeficiency.
    Incefy GS; O'Reilly RJ; Kapoor N; Iwata T; Good RA
    Transplantation; 1981 Oct; 32(4):299-305. PubMed ID: 6977211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo enhancement of mixed lymphocyte culture reactivity by thymosin in patients with primary immunodeficiency disease.
    Wara DW; Barrett DJ; Ammann AJ; Cowan MJ
    Ann N Y Acad Sci; 1979; 332():128-34. PubMed ID: 161150
    [No Abstract]   [Full Text] [Related]  

  • 5. Induction of E-rosette-promoting factor in human plasma by levamisole: an assessment in a patient with partial DiGeorge syndrome.
    Seki H; Yokoi T; Kubo M; Moriya N; Miyawaki T; Nagaoki T; Miura M; Taniguchi N
    Scand J Immunol; 1982 Feb; 15(2):141-8. PubMed ID: 6980445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The thymus in immunodeficiency diseases: new therapeutic approaches.
    Bach JF
    Birth Defects Orig Artic Ser; 1983; 19(3):245-53. PubMed ID: 6360235
    [No Abstract]   [Full Text] [Related]  

  • 7. A case of Di George syndrome treated with thymopoietin pentapeptide (TP-5) demonstrating an adherent suppressor cell of lymphocyte function.
    Joffe MI; Sochett E; Pettifor JM; Rabson AR
    J Clin Lab Immunol; 1982 May; 8(1):69-73. PubMed ID: 6212686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymosin therapy in the DiGeorge syndrome.
    Barrett DJ; Wara DW; Ammann AJ; Cowan MJ
    J Pediatr; 1980 Jul; 97(1):66-71. PubMed ID: 7381650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymosin-induced leukocyte histamine release reaction in an infant with DiGeorge syndrome.
    Bamzai AK; Kretschmer RR; Rothberg RM; Gotoff SP
    Clin Immunol Immunopathol; 1979 Sep; 14(1):70-6. PubMed ID: 89923
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunological and clinical investigation of a bovine thymic extract. I. "In vitro" effect on T-cell differentiation in normal and pathological conditions.
    Fiorilli M; Ammirati P; Pandolfi F; Sirianni MC; Aiuti F
    Ann Sclavo; 1979; 21(4):494-501. PubMed ID: 317988
    [No Abstract]   [Full Text] [Related]  

  • 11. Biological and clinical properties of THF.
    Trainin N; Handzel ZT; Pecht M
    Thymus; 1985; 7(3):137-50. PubMed ID: 3875914
    [No Abstract]   [Full Text] [Related]  

  • 12. Thymic peptide hormones: basic properties and clinical applications in cancer.
    Schulof RS
    Crit Rev Oncol Hematol; 1985; 3(4):309-76. PubMed ID: 3902261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thymic function in man.
    Pahwa R; Ikehara S; Pahwa SG; Good RA
    Thymus; 1979 Sep; 1(1-2):27-58. PubMed ID: 317931
    [No Abstract]   [Full Text] [Related]  

  • 14. Results in two infants with the DiGeorge syndrome--effects of long-term TP5.
    Businco L; Rubaltelli FF; Paganelli R; Galli E; Ensoli B; Betti P; Aiuti F
    Clin Immunol Immunopathol; 1986 May; 39(2):222-30. PubMed ID: 3084141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thymic factors.
    Bach JF; Carnaud C
    Prog Allergy; 1976; 21():342-408. PubMed ID: 12517
    [No Abstract]   [Full Text] [Related]  

  • 16. Thymic hormones--a clinical update.
    Sztein MB; Goldstein AL
    Springer Semin Immunopathol; 1986; 9(1):1-18. PubMed ID: 3014672
    [No Abstract]   [Full Text] [Related]  

  • 17. Thymic hormone in the treatment of cancer.
    Dardeene M; Bach JF
    Prog Clin Biol Res; 1989; 288():363-82. PubMed ID: 2654955
    [No Abstract]   [Full Text] [Related]  

  • 18. [Thymus hormone reviewed].
    Brugo MA; Valcurone G; Tassi GC
    Recenti Prog Med; 1978 Sep; 65(3):244-76. PubMed ID: 360328
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro and in vivo responses to thymosin in severe combined immunodeficiency.
    Mawhinney H; Gleadhill VF; McCrea S
    Clin Immunol Immunopathol; 1979 Oct; 14(2):196-203. PubMed ID: 314879
    [No Abstract]   [Full Text] [Related]  

  • 20. Thymopoietin pentapeptide treatment of primary immunodeficiencies.
    Aiuti F; Businco L; Fiorilli M; Galli E; Quinti I; Rossi P; Seminara R; Goldstein G
    Lancet; 1983 Mar; 1(8324):551-4. PubMed ID: 6131256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.